Healthcare (Basel, Switzerland)

How Brain Inflammation May Link Mental Illnesses and Physical Diseases

Updated

Abstract

is linked to the co-occurrence of psychiatric disorders and internal diseases, affecting care and treatment outcomes.

  • Psychiatric disorders and internal diseases often share overlapping symptoms and mechanisms.
  • Neuroinflammation may play a central role in the relationship between these conditions.
  • Factors such as systemic inflammation, dysregulation, and ANS imbalance contribute to neuroinflammation.
  • There are notable gaps in longitudinal studies and biomarker validation regarding these comorbidities.
  • Emerging therapies like IL-6 inhibitors and behavioral interventions are promising but remain underexplored.
  • Research representation disparities may limit the generalizability of findings and highlight the need for inclusive trials.

Simplified

Key numbers

2×
Increased Mortality Risk
Mortality risk in patients with comorbid conditions.
20–30%
Depression Prevalence in CVD Patients
Percentage of CVD patients experiencing depression.
42.3%
Diabetes and Depression
Percentage of type 2 diabetes patients with depression symptoms.

Full Text

What this is

  • Psychiatric disorders and internal diseases often co-occur, complicating treatment and increasing healthcare burdens.
  • is identified as a key mechanism linking these conditions, influenced by systemic inflammation and dysregulation of the .
  • This review synthesizes evidence on 's role in comorbidities like depression, anxiety, cardiovascular disease, and diabetes.
  • It emphasizes the need for integrated care approaches and identifies gaps in research and clinical practice.

Essence

  • serves as a critical link between psychiatric disorders and internal diseases, impacting treatment outcomes. Addressing this connection through integrated care models is essential for improving patient health and reducing healthcare costs.

Key takeaways

  • is a central mechanism connecting psychiatric disorders and internal diseases. Elevated cytokines like IL-6 and TNF-α contribute to both conditions, creating a cycle of worsening health outcomes.
  • Individuals with comorbid psychiatric and chronic medical conditions face significantly higher risks, including a twofold increase in all-cause mortality. This underscores the need for integrated care strategies that address both mental and physical health.
  • Emerging therapies targeting , such as IL-6 inhibitors and vagus nerve stimulation, show promise but require further exploration in combined applications to optimize treatment for comorbidities.

Caveats

  • Current research is primarily cross-sectional, limiting the ability to determine causality between and comorbid conditions. Longitudinal studies are needed to clarify these relationships.
  • There is a lack of validated biomarkers for diagnosing and monitoring in clinical settings, which hampers effective treatment strategies.
  • Disparities in research representation may affect the generalizability of findings, highlighting the need for inclusive clinical trials.

Definitions

  • neuroinflammation: Inflammation of the nervous tissue, often linked to chronic diseases and psychiatric disorders, driven by systemic inflammatory processes.
  • HPA axis: Hypothalamic-pituitary-adrenal axis, a central stress response system that regulates hormonal responses to stress and influences inflammation.

Simplified

Funding

Competing interests

The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free